市場調查報告書
商品編碼
1410818
輸尿管鏡市場:按細分市場劃分的規模、份額、法規、報銷、程序、安裝基礎、到 2033 年的預測Ureteroscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
輸尿管鏡的市場規模受到多種因素的推動,例如人口老化、腎結石患者數量的增加以及腎臟、輸尿管和膀胱的其他疾病。
全球患有泌尿系統疾病的人數持續增加,估計全球有超過2億人患有腎臟疾病。輸尿管鏡是一種用於向這些患者給藥的裝置。隨著泌尿系統疾病患者數量的增加,需要輸尿管鏡的醫院數量也會增加,輸尿管鏡市場可望擴大。
該報告深入探討了全球輸尿管鏡市場,包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。
Ureteroscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Endoscopy Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Ureteroscopes market for the year 2020 and beyond. The Ureteroscopes market is driven by a variety of factors, including a growing aging population, increase in patients with kidney stones, and other conditions of the kidney, ureter, and bladder.
The global population with urological disorders continues to increase with more than 200 million people worldwide estimated to have kidney disorders. Ureteroscopes are devices used to administer medication to these patients. This rising number of patients with urological disorders is expect to result in a larger number of hospitals that require Ureteroscopes, resulting in an increase in the market for Ureteroscopes.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Ureteroscopes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: KARL STORZ SE & Co KG, Hoya Corp, Olympus Corp, National Advanced Endoscopy Devices, Inc., Richard Wolf GmbH, Stryker Corp, Boston Scientific Corp, NeoScope Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable